AGN — Argenica Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$56.52m
- AU$48.09m
- AU$0.06m
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Changes in Working Capital | 0 | 0 | 0.002 | 0.781 |
Other Operating Cash Flow | ||||
Cash from Operating Activities | -0.059 | -1.05 | -3.36 | -3.3 |
Other Investing Cash Flow Items | — | — | — | -0.05 |
Change in Net Investments | ||||
Cash from Investing Activities | — | — | — | -0.05 |
Financing Cash Flow Items | — | 0 | 0 | 0 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Cash from Financing Activities | 0.401 | 7.85 | 5.13 | 3.73 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 0.342 | 6.8 | 1.77 | 0.375 |